Applications - Platypus
Applications, Recent results, Publications.
Showing 421 - 440 of 548 results
Applications, Recent results, Publications.
Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape
Role at ANSTO
Andrew Douglas is Founder & Managing Director of Kandui Technologies.
Exploring the interaction of polystyrene nanoplastics and blood plasma proteins.
Originally from Switzerland, Dr Häusermann gained his PhD in x-ray diffraction and synchrotron techniques at King’s College London.
An environmental study supported by a citizen science project at ANSTO and UNSW has brought greater understanding of the movement of birds between all of Australia’s major water basins and the importance of the Murray-Darling River Basin.
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.
A collaboration of scientists from RMIT, ANSTO and the CSIRO has published pioneering research that brings new insights into intrinsically disordered proteins and protein regions (IDPs)/ (IDRs) and how they behave under various physiological processes.
Terry has studied in Singapore and Australia, focusing on teaching design. He is passionate about cross-cultural interactive learning and design research to inspire new and innovative concepts.
A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
A team of Melbourne researchers and international partners from Italian Instituto Nazionale de Fisica Nucleare (INFN) and CERN, who are developing radiation-hardened semiconductor chips, used the unique state-of-art high energy ion microprobe on the SIRIUS ion accelerator at ANSTO’s Centre for Accelerator Science to test a prototype radiation-resistant computer chip
A unique scientific capability comprising a single research platform for high-fidelity simulation, real-time dosimetry, and biological response data is available all from a neutron instrument.
Dr Karin Soldenhoff is a Principal Consultant within ANSTO's minerals area, managing the process development and research groups.
John is currently one of two co-Directors of the Health Research and Technology Group at ANSTO.
He is Director of the ANSTO node of the NCRIS National Imaging Facility and is a member of the NIF Scientific Advisory Committee.